Isa AN, Yavuz YESİLOVA, Ismail IYNEN, Osman TANRIKULU, Ahmet YÜKKALDIRAN, Mahmut DEMİR, Mustafa AKSOY

The frequency of laryngeal involvement in lipoid proteinosis patients

Aim: Lipoid proteinosis (LP) is a rare autosomal recessive disorder that occurs with the accumulation of hyaline substance in oralcavity, laryngeal mucosa and skin. The aim of this study was to investigate the incidence of laryngeal involvement in patients withLP which have hoarseness and skin lesions, and the areas of hyaline substance accumulation in the larynx.Material and Methods: In this study, 21 patients who were admitted to our Dermatology outpatient clinic between January 2013 andDecember 2017 and diagnosed as LP with punch biopsy were evaluated. Laryngeal imaging was performed in otorhinolaryngologyclinic, and the frequency of larynx involvement and the areas of hyaline accumulation in the larynx were evaluated.Results: Twenty-one patients with hoarseness and diagnosed by skin biopsy as LP were included in the study. Thickening ofthe vocal cords in 21 patients (100%); thickening and hypertrophic changes of arytenoids in 13 patients (61.9%); thickening andhypertrophic changes of the interarytenoid area in 10 patients (47.6%); thickeningand hypertrophic changes of epiglottis in 3 (14.3%)patients; hypertrophic changes and thickening of the aryepiglottic fold in 3 patients (14.3%); thickening and hypertrophic changes ofventricular folds in 2 patients (9.5%) were observed.Conclusion: In our study, similar to the data in the literature, the pathological changes were most frequently seen in the vocal cordsand the least in the ventricle band, aryepiglottic fold and epiglottis. In order to better understand the laryngeal involvement and theareas of involvement in LP patients, studies with more patients are needed.

PDF

___

1. Mcgrath JA. Lipoid proteinosis. Handb Clin Neurol 2015;132:317-22.
2. Urbach E, Wiethe C. Lipoidosis cutis et mucosae. Virchows Arch A Pathol (Pathol Anat) 1929;273:285-319.
3. Desmet S, Devos SA, Chan I, et al. Clinical and molecular abnormalities in lipoid proteinosis. Eur J Dermatol 2005;15:344-6.
4. Gao D, Ma X, Lian P, et al. Pathogenetic mechanism of lipoid proteinosis caused by mutation of the extracellular matrix protein 1 gene. Mol Med Rep 2018;17:8087-90.
5. Dertlioğlu SB, Çalık M, Çiçek D. Demographic, clinical, and radiologic signs and treatment responses of lipoid proteinosis patients: a 10-case series from Şanlıurfa. Int J Dermatol 2014;53:516-23.
6. Baykal C, Topkarci Z, Yazganoglu KD, et al. Lipoid proteinosis: a case series from Istanbul. Int J Dermatol 2007;46:1011-6.
7. Güvener G, Kocabay C, Huq GE, et al. Lipoid proteinosis in the mouth and laryngeal structures: a case report. Kulak Burun Bogaz Ihtis Derg 2007;17:105-7.
8. Kartal D, Çınar SL, Kartal L, et al. Lipoid proteinosis. Acta Dermatovenerol Alp Pannonica Adriat 2016;25:19-21.
9. Acar A, Eryilmaz A, Gocer C, et al. Lipoid proteinosis of larynx: review of four cases. Int J Pediatr Otorhinolaryngol 2004;68:1557-61.
10. Sriwastava S, Desai A, Yuliati A, et al. Child with a hoarse cry and intracranial calcification. Pediatr Neurol 2018;87:78-9.
11. Koganti D. Urbach-wiethe disease: a rare cause of hoarseness of voice. Int J Phonosurg Laryngol 2013;3:61-4.
12. Bai X, Liu JW, Ma DL. Novel mutations in extracellular matrix protein 1 gene in a chinese patient with lipoid proteinosis. Chin Med J (Engl) 2016;129:2765-6.
13. Ally M, Kinshuck AJ, Sandison A, et al. The management of laryngeal lipoid proteinosis. J Laryngol Otol 2018;132:936- 9.
14. Loos E, Kerkhofs L, Laureyns G. Lipoid proteinosis: a rare cause of hoarseness. J Voice 2019;33:155-8.
15. Karaman H, Soyuer I, Külahcı İ, et al. Lipoid proteinosis (Urbach-Wiethe’s Disease) Kulak Burun Bogaz Ihtis Derg 2015;25:357-60.
16. Oz F, Kalekoğlu N, Karakullukçu B, Lipoid proteinosis of the larynx. J Laryngol Otol 2002;116:736-9.
17. Kaya TI, Tursen U, Kokturk A, et al. The early erosive vesicular stage of lipoid proteinosis: clinical and histopathological features. Br J Dermatol 2003;148:380-2.
18. Kaya TI, Kokturk A, Tursen U, et al. D-penicillamine treatment for lipoid proteinosis. Pediatr Dermatol 2002;19:359-62.
19. Gruber F, Manestar D, Stasic A, et al. Treatment of lipoid proteinosis with etretinate. Acta Derm Venereol 1996;76:154-5.
20. Kroukamp G, Lehmann K. Treatment of laryngeal lipoid proteinosis using CO2 laser. S Afr Med J 2007;97:90-2.
21. Savage MM, Crockett DM, McCabe BF. Lipoid proteinosis of larynx: a cause of voice change in the infant and young child. Int J Pediatr Otorhinolaryngol 1988;15:33-8.
22. Bozdağ KE, Gül Y, Karaman A. Lipoid proteinosis. Int J Dermatol 2000;39:203-4.
23. Staut CC, Naidich TP. Urbach-Wiethe disease (Lipoid proteinosis). Pediatr Neurosurg 1998;28:212-4.
24. Harper JI, Duguid KP, Staughton RC, Oropharyngeal and laryngeal lesions in lipoid proteinosis. J Laryngol Otol 1983;97:877-80.
25. Aziz MT, Mandour MA, el-Ghazzawi IF, et al. Urbach-wiethe disease in O.R.L. practice. (a clinical and histochemical study of the laryngeal lesions). J Laryngol Otol 1980;94:1309-19.
26. Dıckey RF, Davıs S 2nd. Lipoidd proteinosis (Urbach-wiethe); report of a case and revıew. Ann Otol Rhinol Laryngol 1964;73:287-96.
27. Hofer PA, Ohman J. Laryngeal lesions in Urbach-Wiethe disease (lipoglycoproteinosis; lipoid proteinosis; hyalinosis cutis et mucosae). A histopathological and clinical study, including direct laryngoscopical examinations. Acta Pathol Microbiol Scand A 1974;82:547-58.
28. Xu W, Wang L, Zhang L, Otolaryngological manifestations and genetic characteristics of lipoid proteinosis. Ann Otol Rhinol Laryngol 2010;119:767-71.